Adare Pharma Solutions Capacity Update October 2023: Small Molecule
Source: Adare Pharma Solutions
Renard Jackson, Vice President Operations, North America, presents an overview of Adare’s integrated end-to-end oral dose capabilities, with a focus on high potency capacity and the recently expanded packaging and serialization capabilities at our Philadelphia facilities.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Adare Pharma Solutions
This website uses cookies to ensure you get the best experience on our website. Learn more